From The Editor
-
A D&I Program Worth Replicating
9/1/2022
Ninety-four percent of PhRMA’s member companies responding to a survey published in December 2020 reported the existence of “employee resource groups” within their organizations, defined as an “employer recognized group of employees who share the concerns of a common race, gender, national origin, or sexual orientation.”
-
Representation Matters. Location Does Too.
8/1/2022
Representation at the top of any profession, whether jurisprudence or biotechnology, works as an accelerator for younger generations to follow.
-
Scouting Turbulence For Opportunity
7/1/2022
With bad news in the headlines at home and globally, and a seesawing public market capable of wiping years of value from company books almost overnight, it can be difficult to remain focused on the bread-and-butter tasks that keep a company afloat.
-
From Summer Stroll To Summer Hustle
6/1/2022
As news reporter covering the biopharmaceutical industry in the early aughts, the summer months could present a different kind of challenge.
-
A New Golden Age Of Psychedelic Therapy? Proceed With Caution
5/2/2022
Is it time to stop worrying and love the drugs? Psychedelic medicines promise a radical solution to endemic mental health conditions, but caution is needed to cross the finish line.
-
Who Are The “Right” People?
4/1/2022
It always will be important for business leaders to surround themselves with the right people. The thing to remember, however, is that there are many variables to determine who the “right” person is.